Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E8YH
|
||||
| Former ID |
DIB000088
|
||||
| Drug Name |
NCX 1022
|
||||
| Indication | Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] | Phase 2 | [1] | ||
| Company |
NicOx SA
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Clinical pipeline report, company report or official report of NicOx SA. | ||||
| REF 2 | Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol. 2004 Nov;143(5):618-25. Epub 2004 Aug 16. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.